Dafin F. Muresanu
Dafin F. Muresanu, MD, PhD, MBA, FANA
Professor of Neurology, Senior Neurologist, Chairman of the Neurosciences Department, Faculty of Medicine, “Iuliu Hatieganu” University of Medicine and Pharmacy Cluj-Napoca, President of the European Federation of Neurorehabilitation Societies (EFNR), Co-Chair EAN Scientific Panel Neurorehabilitation, Past President of the Romanian Society of Neurology, President of the Society for the Study of Neuroprotection and Neuroplasticity (SSNN), member of the Academy of Medical Sciences, Romania, secretary of its Cluj Branch. His activity includes involvement in many national and international clinical studies and research projects, over 400 scientific participations as “invited speaker” in national and international scientific events, a significant portfolio of scientific articles (190 papers indexed on Web of Science-ISI, H-index: 20) as well as contributions in monographs and books published by prestigious international publishing houses.
Title of presentation: Advances in neurorehabilitation science: the role of biomarkers as prognostic factors.
Short abstract
A stroke recovery biomarker can be defined as an indicator of disease state that can be used as a measure of underlying molecular/cellular processes and structural and functional connectivity. These could be used to understand outcome, or predict recovery or treatment response. In practical terms, biomarkers should improve our ability to predict long-term outcomes after stroke across multiple domains. This is beneficial for patients, caregivers and clinicians as well as for planning subsequent clinical pathways and goal setting. This presentation aims to deliver the latest progress in the field.
Professor of Neurology, Senior Neurologist, Chairman of the Neurosciences Department, Faculty of Medicine, “Iuliu Hatieganu” University of Medicine and Pharmacy Cluj-Napoca, President of the European Federation of Neurorehabilitation Societies (EFNR), Co-Chair EAN Scientific Panel Neurorehabilitation, Past President of the Romanian Society of Neurology, President of the Society for the Study of Neuroprotection and Neuroplasticity (SSNN), member of the Academy of Medical Sciences, Romania, secretary of its Cluj Branch. His activity includes involvement in many national and international clinical studies and research projects, over 400 scientific participations as “invited speaker” in national and international scientific events, a significant portfolio of scientific articles (190 papers indexed on Web of Science-ISI, H-index: 20) as well as contributions in monographs and books published by prestigious international publishing houses.
Title of presentation: Advances in neurorehabilitation science: the role of biomarkers as prognostic factors.
Short abstract
A stroke recovery biomarker can be defined as an indicator of disease state that can be used as a measure of underlying molecular/cellular processes and structural and functional connectivity. These could be used to understand outcome, or predict recovery or treatment response. In practical terms, biomarkers should improve our ability to predict long-term outcomes after stroke across multiple domains. This is beneficial for patients, caregivers and clinicians as well as for planning subsequent clinical pathways and goal setting. This presentation aims to deliver the latest progress in the field.
